Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will ...

AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...

AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...

"AbbVie expands North Chicago API production with $195m investment" was originally created and published by Pharmaceutical ...

NORTH CHICAGO Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) today ...

Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) have announced a ...

AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, creating at least 50 new jobs within the next three years.

Drugmaker AbbVie plans to construct a $195 million facility near its headquarters in North Chicago to manufacture active pharmaceutical ingredients, The Chicago Tribune reported Aug. 12. Construction ...

Fatal crash involved Guatemalan national The Stephenson County Sheriff’s Department says toxicology testing will be conducted ...